1 – 20 of 28
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Exploring Definitions and Predictors of Response to Biologics for Severe Asthma
2024) In Journal of Allergy and Clinical Immunology: In Practice(
- Contribution to journal › Article
-
Mark
Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma
2024) In Annals of Allergy, Asthma and Immunology(
- Contribution to journal › Article
- 2023
-
Mark
Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both
(
- Contribution to journal › Article
- 2021
-
Mark
Management of asthma in childhood : Study protocol of a systematic evidence update by the Paediatric Asthma in Real Life (PeARL) Think Tank
(
- Contribution to journal › Article
-
Mark
Eosinophilic and Noneosinophilic Asthma : An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort
(
- Contribution to journal › Article
- 2020
-
Mark
Point-of-care biomarkers in asthma management : Time to move forward
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Research Priorities in Pediatric Asthma : Results of a Global Survey of Multiple Stakeholder Groups by the Pediatric Asthma in Real Life (PeARL) Think Tank
(
- Contribution to journal › Article
-
Mark
International severe asthma registry (ISAR) : protocol for a global registry
(
- Contribution to journal › Article
- 2019
-
Mark
Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
(
- Contribution to journal › Article
-
Mark
The REal Life EVidence AssessmeNt Tool (RELEVANT) : Development of a novel quality assurance asset to rate observational comparative effectiveness research studies
(
- Contribution to journal › Article
-
Mark
Quality standards in respiratory real-life effectiveness research : The REal Life EVidence AssessmeNt Tool (RELEVANT): Report from the Respiratory Effectiveness Group - European Academy of Allergy and Clinical Immunology Task Force
(
- Contribution to journal › Article
-
Mark
Prevalence and characteristics of asthma-chronic obstructive pulmonary disease overlap in routine primary care practices
(
- Contribution to journal › Article
- 2018
-
Mark
Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK
(
- Contribution to journal › Article
-
Mark
Inhaler technique mastery and maintenance in healthcare professionals trained on different devices
(
- Contribution to journal › Article
-
Mark
Relationship of Inhaled Corticosteroid Adherence to Asthma Exacerbations in Patients with Moderate-to-Severe Asthma
(
- Contribution to journal › Article
- 2017
-
Mark
Asthma referrals : A key component of asthma management that needs to be addressed
(
- Contribution to journal › Scientific review
-
Mark
Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia
(
- Contribution to journal › Article
- 2016
-
Mark
The Relationship Between 24-Hour Symptoms and COPD Exacerbations and Healthcare Resource Use : Results from an Observational Study (ASSESS)
(
- Contribution to journal › Article
-
Mark
Incidence of oral thrush in patients with COPD prescribed inhaled corticosteroids : Effect of drug, dose, and device
(
- Contribution to journal › Article
- 2014
-
Mark
Integrating evidence for managing asthma in patients who smoke.
(
- Contribution to journal › Scientific review